다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
vTv Therapeutics Inc (VTVT)
vTv Therapeutics Inc (VTVT) 뉴스

VTVT

vTv Therapeutics (VTVT)

vTv Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VTVT

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/03/19	21:30	PR Newswire (US)	CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT	NASDAQ:VTVT	vTv Therapeutics Inc
2024/03/13	21:00	GlobeNewswire Inc.	vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update	NASDAQ:VTVT	vTv Therapeutics Inc
2024/03/08	06:47	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:VTVT	vTv Therapeutics Inc
2024/03/08	04:34	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:VTVT	vTv Therapeutics Inc
2024/03/06	09:52	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	NASDAQ:VTVT	vTv Therapeutics Inc
2024/03/05	22:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTVT	vTv Therapeutics Inc
2024/03/04	22:00	GlobeNewswire Inc.	vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes	NASDAQ:VTVT	vTv Therapeutics Inc
2024/03/01	22:00	GlobeNewswire Inc.	vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference	NASDAQ:VTVT	vTv Therapeutics Inc
2024/03/01	09:34	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:VTVT	vTv Therapeutics Inc
2024/02/28	23:26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTVT	vTv Therapeutics Inc
2024/02/28	23:14	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:VTVT	vTv Therapeutics Inc
2024/02/28	22:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTVT	vTv Therapeutics Inc
2024/02/28	22:00	GlobeNewswire Inc.	vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund	NASDAQ:VTVT	vTv Therapeutics Inc
2024/02/23	06:00	PR Newswire (US)	CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCE	NASDAQ:VTVT	vTv Therapeutics Inc
2023/12/23	06:26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTVT	vTv Therapeutics Inc
2023/12/20	06:28	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTVT	vTv Therapeutics Inc
2023/12/13	06:21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTVT	vTv Therapeutics Inc
2023/11/21	06:23	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTVT	vTv Therapeutics Inc
2023/11/15	22:22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTVT	vTv Therapeutics Inc
2023/11/15	22:19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTVT	vTv Therapeutics Inc
2023/11/10	06:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VTVT	vTv Therapeutics Inc
2023/11/10	06:30	GlobeNewswire Inc.	vTv Therapeutics Announces 2023 Third Quarter Financial Results and Provides Corporate Update	NASDAQ:VTVT	vTv Therapeutics Inc
2023/11/10	06:20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTVT	vTv Therapeutics Inc
2023/11/08	22:00	GlobeNewswire Inc.	vTv Therapeutics to Participate at the Stifel 2023 Healthcare Conference	NASDAQ:VTVT	vTv Therapeutics Inc
2023/11/02	21:00	GlobeNewswire Inc.	vTv Therapeutics Appoints Thomas Strack, M.D., as Chief Medical Officer	NASDAQ:VTVT	vTv Therapeutics Inc
2023/11/01	21:24	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTVT	vTv Therapeutics Inc
2023/11/01	21:00	GlobeNewswire Inc.	vTv Therapeutics Announces Sale of Shares in Reneo Pharmaceuticals for Proceeds of $4.4 Million	NASDAQ:VTVT	vTv Therapeutics Inc
2023/09/27	21:30	PR Newswire (US)	CANTEX AND MICHIGAN MEDICINE ANNOUNCE INITIATION OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 3 PIVOTAL CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF AZELIRAGON IN THE TREATMENT OF PATIENTS HOSPITALIZED FOR COVID-19	NASDAQ:VTVT	vTv Therapeutics Inc
2023/09/26	21:30	PR Newswire (US)	Cantex and Allegheny Health Network Announce Initiation of a Phase 1/2 Study of Azeliragon in Patients Refractory to First-Line Treatment of Metastatic Pancreatic Cancer	NASDAQ:VTVT	vTv Therapeutics Inc
2023/09/26	05:20	Edgar (US Regulatory)	Form DEF 14C - Other definitive information statements	NASDAQ:VTVT	vTv Therapeutics Inc

검색 관련기사 보기:NASDAQ:VTVT

1 2 3 4 5 6 7 8 9 10 다음 >>

US Dollar vs Sterling

American Express

US Dollar vs Euro

BNP Paribas (QX)

Financial Select Sector

Energy Select Sector SPDR

Health Care Select Sector

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관